[1] DeWaele L,Lagae L,Mekahli D.Tuberous sclerosis complex:the past and the future[J].Pediatr Nephrol,2015,30(10):1771~1780. [2] Kwiatkowski DJ,Manning BD.Molecular basis of giant cells in tuberous sclerosis complex[J].N Engl J Med,2014,371(8):778~780. [3] 王苗,杨理明,杨赛,等.儿童结节性硬化症合并癫痫临床特点及基因分析[J].国际儿科学杂志,2020,47(11):814~817. [4] Curatolo P,Specchio N,Aronica E.Advances in the genetics and neuropathology of tuberous sclerosis complex:edging closer to targeted therapy[J].Lancet Neurol,2022,21(9):843~856. [5] Amin S,Lux A,Calder N,Laugharne,M,Osborne,J,O'callaghan,F.Causes of mortality in individuals with tuberous sclerosis complex[J].Dev Med Child Neurol ,2017, 59(6):612~617. [6] Jacks SK,Witman PM.Tuberous Sclerosis Complex:An Update for Dermatologists[J].Pediatr Dermatol,2015; 32(5):563~570. [7] Hodgson N,Kinori M,Goldbaum,MH,et al.Ophthalmic manifestations of tuberous sclerosis:a review[J].Clin Exp Ophthalmol.2017,45(1):81~86. [8] Budde K,Gaedeke J.Tuberous sclerosis complex-associated angiomyolipomas:focus on mTOR inhibition[J].Am J Kidney Dis,2012,59(2):276~283. [9] Nabbout R,Belousova E,Benedik MP,et al.Epilepsy in tuberous sclerosis complex:Findings from the TOSCA Study[J].Epilepsia Open, 2018, 4(1):73~84. [10] Kotulska K,Kwiatkowski DJ,Curatolo P,et al.Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial[J].Ann Neurol,2021,89(2):304~314. [11] Curatolo P,Nabbout R,Lagae L,et al.Management of epilepsy associated with tuberous sclerosis complex:Updated clinical recommendations[J].Eur J Paediatr Neurol,2018,22(5):738~748. [12] Słowińska,M,Kotulska K,Szymańska S,et al.Approach to preventive epilepsy treatment in tuberous sclerosis complex and current clinical practice in 23 countries[J].Pediatr Neurol,2021,115:21~27. [13] Alsowat D,Zak M,McCoy B,et al.A review of investigations for patients with tuberous sclerosis complex who were referred to the tuberous sclerosis clinic at the hospital for sick children:identifying gaps in surveillance[J].Pediatr Neurol,2020,102:44~48. [14] Kohrman,MH.Emerging treatments in the management of tuberous sclerosis complex[J].Pediatr Neurol,2012,46(5):267~275. [15] Serra I,Scheldeman C,Bazelot M,et al.Cannabidiol modulates phosphorylated rpS6 signalling in a zebrafish model of Tuberous Sclerosis Complex[J].Behav Brain Res,2019,363 135~144. [16] Fang Y,Li D,Wang M,et al.Ketogenic diet therapy for drug-resistant epilepsy and cognitive impairment in children with tuberous sclerosis complex[J].Front Neurol.2022,13:863826. [17] d'Orio P,Pelliccia V,Biondi,D,et al.Surgery for tuberous sclerosis complex-related epilepsy:Risk factors for an unfavorable seizure outcome[J].Seizure,2022,97:8~14. [18] Vannicola C,Tassi L,Barba C,et al.Seizure outcome after epilepsy surgery in tuberous sclerosis complex:results and analysis of predictors from a multicenter study[J].J Neurol Sci,2021,427:117506. |